CAR T-Cell Therapy for Autoimmune Diseases: Free Eligibility Check for Lupus, Rheumatoid Arthritis, and More

JAN 2025 Update: The program is currently suspended for international patients. We will provide updates as soon as it reopens. Please contact us to stay informed.

CAR T-cell therapy is emerging as a promising approach for treating severe autoimmune diseases by targeting B cells, which play a crucial role in the pathogenesis of these conditions.

As of 2024, CAR T-cell therapy programs have opened for the following conditions:

• Lupus
• Rheumatoid arthritis
• Scleroderma
• Dermatomyositis
• Vasculitis

Contact us to check if you are eligible for this treatment—this is a free service.

More about CAR-T therapy for Lupus